Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

805.23 -20.68 (-2.50%)
Official Closing Price Updated: 4:10 PM EDT, Apr 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,986,211
Open 818.60
Bid (Size) 804.00 (2)
Ask (Size) 805.07 (1)
Prev. Close 825.91
Today's Range 797.00 - 820.66
52wk Range 711.40 - 972.53
Shares Outstanding N/A
Dividend Yield 0.65%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Hims & Hers Health Stock Soared Tuesday
Via The Motley Fool
Topics Stocks
Exposures US Equities
Hims & Hers Health Stock Jumped Tuesday Afternoon: What Happened?
Hims & Hers Health Inc (NYSE:HIMS) shares spiked higher in afternoon trading Tuesday after the company said it will offer Eli Lilly And Co's (NYSE:LLY) Zepbound through its Telehealth platform. 
Via Benzinga

Performance

YTD
+3.5%
+3.5%
1 Month
-13.4%
-13.4%
3 Month
+4.1%
+4.1%
6 Month
-9.1%
-9.1%
1 Year
+5.9%
+5.9%

More News

Read More
Hims & Hers Health (HIMS) Stock Trades Up, Here Is Why
Via StockStory
Topics Artificial Intelligence Supply Chain
Exposures Artificial Intelligence Product Safety Supply Chain
Hims Stock Rockets After Inking Deal To Sell Eli Lilly's Obesity Drug, Zepbound
Via Investor's Business Daily
Exposures Product Safety
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Check Out What Whales Are Doing With LLY
Via Benzinga
Biotech Stocks Take Another Beating As 'Chaos' Reigns At FDA With Reports Of Mass Firings
Via Investor's Business Daily
Topics Workforce
Exposures COVID-19 Layoff Product Safety
If Nearly Half of S&P 500 Stocks Are Up in 2025, Then Why Is the Index Down 5%?
Via The Motley Fool
Topics Stocks
Exposures US Equities
Where Will Eli Lilly Be in 1 Year?
Via The Motley Fool
Exposures Product Safety
The Vanguard S&P 500 ETF Is Sinking, but This Wall Street Analyst Predicts It Will Soar 168% by 2030
Via The Motley Fool
Topics ETFs Economy Stocks
Exposures Economy US Equities
Who Is Peter Thiel's Protégé, Michael Kratsios, Now Leading Trump's AI Strategy Amid Rising Tech Tensions With China
Via Benzinga
Topics Artificial Intelligence Government
Exposures Artificial Intelligence Political
Eli Lilly's Cholesterol Drug Reduces Genetic Heart Disease Risk Factor By 93.9%
Via Benzinga
Palatin Technologies' Obesity Drug Co-Administered With Eli Lilly's Blockbuster Drug Shows 4.4% Reduction In Weight
Via Benzinga
Which Healthcare Stock Is the Best Buy Right Now?
Via MarketBeat
1 Growth Stock With Major Catalysts on the Way to Buy and Hold
Via The Motley Fool
Is Hims & Hers Stock Too Cheap to Pass Up?
Via The Motley Fool
Benzinga Bulls And Bears: Chevron, Microsoft, Nike — And Tariffs Have Automotive Sector Reeling
Via Benzinga
Microsoft Co-Founder Bill Gates Praises China As A Pioneer In Solar, Batteries, And AI: Warns Tensions Are Stifling Global Innovation
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Eli Lilly Stock Up 1% After Key Signal, Despite S&P 500's ~2% Drop
Via Benzinga
Topics Stocks
Exposures US Equities
European Drug Regulator Gives Thumbs Down To Eli Lilly's Alzheimer's Drug, Analyst Says It Is Incremental Win For Biogen
Via Benzinga
Novo Nordisk Inks Its Second Big Obesity Deal In A Week — And It's Not For A GLP-1
Via Investor's Business Daily
Investors Are Flocking to These 3 Vanguard Sector ETFs. Should You Buy Them Too?
Via The Motley Fool
Topics ETFs Economy Government
Exposures Economy Political Tariff
Billionaires Stanley Druckenmiller, Chase Coleman, and Stephen Mandel Jr. Are Piling Into This Growth Stock That's Beating the S&P 500
Via The Motley Fool
Topics Stocks
Exposures US Equities
Here's How Much $1000 Invested In Eli Lilly 20 Years Ago Would Be Worth Today
Via Benzinga
Why Novo Nordisk Stock Dipped on Thursday
Via The Motley Fool

Frequently Asked Questions

Is Eli Lilly publicly traded?
Yes, Eli Lilly is publicly traded.
What exchange does Eli Lilly trade on?
Eli Lilly trades on the New York Stock Exchange
What is the ticker symbol for Eli Lilly?
The ticker symbol for Eli Lilly is LLY on the New York Stock Exchange
What is the current price of Eli Lilly?
The current price of Eli Lilly is 805.23
When was Eli Lilly last traded?
The last trade of Eli Lilly was at 04/01/25 04:10 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.